Breast Optimization

Your beauty. Your health. You are in control.

Safety, Innovation & Patient Centricity

As a concept created by and unique to Motiva®, breast optimization is about creating a positive, empowering experience for women to collaborate with their surgeons in customizing their desired breast look and feel, using the very best that technological innovation has to offer and a solid foundation of clinical and scientific research.


Qid® Technology





Safety is on the Surface

Over a decade ago, we conducted extensive clinical and scientific research that revealed the risks associated with macrotextured implants outweighed their benefits.That’s why we focused our developments in a new, advanced smooth surface:
SmoothSilk® designed to be biocompatible with your body, our unique and advanced smooth surface minimizes inflammation and reduces the risk of double capsules.

implant comparison with smoothsilk

Information in your hand

While patients may lose implant ID cards or documents, they can never lose a digital passport. Qid® The optional, built-in digital passport allows for non-invasive and instant verification of important implant information at any time after surgery. FDA-cleared, battery-free, and passive radiofrequency identification device.

The blue implant

With traditional implants, surgeons cannot check if an implant’s barrier layer (which is meant to prevent gel bleed into surrounding tissue) is intact before using it. This blue-tinted visual safety barrier allows surgeons to visually ensure the implant shell’s integrity. BluSeal® is a patented safety feature only available with Motiva®

implant comparison with bluseal

The flex is real

This multilayer system is designed to minimize ruptures and leaks, linking all the implant components together to create a unified structure that is highly durable and elastic allowing an easier implant insertion by your surgeon.

For a Soft Look & Feel

We created our own proprietary gels: ProgressiveGel® Plus for structure without compromising softness (used in MOTIVA® ROUND and ANATOMICAL TRUEFIXATION®) and Ultima®for to move naturally with your body, readily adapting to follow your movements. (used in ERGONOMIX®).

Motiva Implants® Safety & Performance Data

Safety and performance data collected through post-market surveillance confirm that SmoothSilk®/SilkSurface® contributes to improved post-operative outcomes with fewer high- and low-risk complications.

A three-year evaluation [1]of 5,813 patients has associated SilkSurface® implants with overall complication and revision rates of under 1%. That same study also reported no cases of rupture due to implant failure, capsular contracture (Baker Grades lll and IV), double capsules, or late seromas.

A six-year prospective study [2] on 35 patients reported no cases of implant rupture or malposition, or of capsular contracture.

Bacterial biofilm accumulates on implant surfaces over time and has been linked to complications such as capsular contracture and breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). A comparative in-vitro evaluation [3] of SmoothSilk®, textured, and traditional smooth implants showed that bacterial attachment and biofilm formation were lowest in SmoothSilk® implants, and highest in textured implants.

First-of-its-kind safety to back-up your decision

Find the perfect look, custom designed for your body

A better journey from consult to surgery

Read what patients have to say

Sforza M, Zaccheddu R, Alleruzzo A et al. Preliminary 3-year evaluation of experience with SilkSurface and VelvetSurface Motiva silicone breast implants: a single-center experience with 5813 consecutive breast augmentation cases. Aesthet Surg J. 2018; 38(Suppl 2):S62-S73.

Chacón M, Chacón M, Fassero J. Six-Year Prospective Outcomes of Primary Breast Augmentation with Nano-Surface Implants. Aesthet Surg J. 2018;39(5):495-508.

James GA, Boegli L, Hancock J, Bowersock L, Parker A, Kinney BM. Bacterial Adhesion and Biofilm Formation on Textured Breast Implant Shell Materials. Aesthetic Plast Surg. 2019 Apr;43(2):490-497. doi: 10.1007/s00266-018-1234-7.